MGIM
M&G Investment Management Portfolio holdings
AUM
$28.2B
1-Year Return
25.82%
This Quarter Return
+11.7%
1 Year Return
+25.82%
3 Year Return
+58.78%
5 Year Return
–
10 Year Return
–
AUM
$40.4M
AUM Growth
+$8.61M
(+27%)
Cap. Flow
+$4.38M
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
61.25%
Holding
778
New
321
Increased
262
Reduced
104
Closed
36
Top Buys
| 1 |
Apple
AAPL
|
$356K |
| 2 |
Microsoft
MSFT
|
$350K |
| 3 |
Amazon
AMZN
|
$219K |
| 4 |
Analog Devices
ADI
|
$145K |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$139K |
Top Sells
| 1 |
Ferguson
FERG
|
$1.7M |
| 2 |
Burford Capital
BUR
|
$268K |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$71.7K |
| 4 |
Alibaba
BABA
|
$68.8K |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$44.9K |
Sector Composition
| 1 | Industrials | 51.55% |
| 2 | Financials | 11.53% |
| 3 | Technology | 9.5% |
| 4 | Healthcare | 7.17% |
| 5 | Consumer Discretionary | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Castle Biosciences
CSTL
$683M
| $6.69K | 0.02% |
+91,678
| New | +$6.69K |
|
327
American International
AIG
$43.9B
| $6.69K | 0.02% |
+139,398
| New | +$6.69K |
|
328
Regeneron Pharmaceuticals
REGN
$60.8B
| $6.69K | 0.02% |
11,967
-915
| -7% | -$512 |
|
329
Quanterix
QTRX
$211M
| $6.68K | 0.02% |
+113,212
| New | +$6.68K |
|
330
Organogenesis Holdings
ORGO
$634M
| $6.63K | 0.02% |
+389,686
| New | +$6.63K |
|
331
Myriad Genetics
MYGN
$615M
| $6.6K | 0.02% |
+212,774
| New | +$6.6K |
|
332
Pebblebrook Hotel Trust
PEB
$1.4B
| $6.59K | 0.02% |
+274,534
| New | +$6.59K |
|
333
Western Digital
WDC
$31.9B
| $6.59K | 0.02% |
122,733
+52,433
| +75% | +$2.81K |
|
334
Plexus
PLXS
$3.75B
| $6.58K | 0.02% |
+72,335
| New | +$6.58K |
|
|
WRK
335
DELISTED
WestRock Company
WRK
| $6.46K | 0.02% |
121,946
+12,644
| +12% | +$670 |
|
336
Micron Technology
MU
$147B
| $6.45K | 0.02% |
75,835
+9,619
| +15% | +$818 |
|
337
Wolverine World Wide
WWW
$2.59B
| $6.39K | 0.02% |
+187,923
| New | +$6.39K |
|
338
Meritage Homes
MTH
$5.89B
| $6.31K | 0.02% |
+134,306
| New | +$6.31K |
|
339
First Merchants
FRME
$2.37B
| $6.29K | 0.02% |
+149,852
| New | +$6.29K |
|
340
Cabot Corp
CBT
$4.31B
| $6.26K | 0.02% |
+109,877
| New | +$6.26K |
|
341
Emergent Biosolutions
EBS
$404M
| $6.26K | 0.02% |
+99,364
| New | +$6.26K |
|
342
NOV
NOV
$4.95B
| $6.26K | 0.02% |
417,361
+1,405
| +0.3% | +$21 |
|
343
Texas Capital Bancshares
TCBI
$3.96B
| $6.19K | 0.02% |
+98,261
| New | +$6.19K |
|
344
Stifel
SF
$11.5B
| $6.17K | 0.02% |
+94,860
| New | +$6.17K |
|
345
Nutanix
NTNX
$18.7B
| $6.11K | 0.02% |
+160,868
| New | +$6.11K |
|
346
Parsons
PSN
$8.08B
| $6.05K | 0.02% |
+155,027
| New | +$6.05K |
|
347
GATX Corp
GATX
$5.97B
| $6.04K | 0.01% |
+68,634
| New | +$6.04K |
|
348
Schlumberger
SLB
$53.4B
| $6.01K | 0.01% |
+187,838
| New | +$6.01K |
|
349
Nucor
NUE
$33.8B
| $5.98K | 0.01% |
62,299
+46,705
| +300% | +$4.48K |
|
350
Enterprise Financial Services Corp
EFSC
$2.24B
| $5.9K | 0.01% |
+128,172
| New | +$5.9K |
|